Investigation of the molecular mechanism of Yiqi Huatan Prescription in the treatment of coronavirus disease 2019 based on network pharmacology
CHEN Xueqing1 LIU Yanzhui2 FENG Jing3 LUO Yuanyuan4 LI Shan5
1.Department of Clinical Laboratory, the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Province, Guangzhou 510040, China;
2.Department of Clinical Laboratory, People’s Hospital of Suixi County, Zhanjiang City, Guangdong Province, Suixi 524300, China;
3.Department of Respiratory Medicine, Zhengzhou Yihe Hospital Affiliated to He’nan University, He’nan Province, Zhengzhou 450046, China;
4.Department of Critical Care Medicine, the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Province, Guangzhou 510040, China;
5.Department of Pathology and Pathophysiology, School of Basic Medicine, He’nan University of Chinese Medicine, He’nan Province, Zhengzhou 450046, China
Abstract：Objective To investigate the molecular mechanism of Yiqi Huatan Prescription in the treatment of coronavirus disease 2019 (COVID-19) by network pharmacology. Methods The active ingredients and potential targets in Yiqi Huatan Prescription were searched by traditional Chinese medicine systems pharmacology database and analysis platform. The drug-ingredient-target network was established. GeneCards database was used to screen the related targets of COVID-19, and STRING database was used to analyze the protein-protein interaction of the common targets of COVID-19 and drug action. Gene ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were performed using DAVID database. Results A total of 145 active ingredients, 267 potential action targets were screened from Yiqi Huatan Prescription, and a total of 251 COVID-19 related targets were screened, 56 targets were obtained through the intersection between the ingredient-target and COVID-19 related targets, and ten key targets were identified after topological analysis. GO analysis showed that Yiqi Huatan Prescription was involved in 57 biological processes, 11 molecular functions and four cellular components, such as inflammation response, immune response, apoptosis process, positive and negative regulation of apoptosis process, proteins binding, enzymes binding, cytokine activity and so on. KEGG analysis obtained 25 pathways including some infectious diseases such as Chagas disease, hepatitis B, pulmonary tuberculosis and pertussis as well as some signaling pathways such as tumor necrosis factor signaling pathway, Toll-like receptor signaling pathway, and mitogen-activated protein kinase signaling pathway. Conclusion Yiqi Huatan Prescription may have potential therapeutic effect against COVID-19 through synergy of multi-functions, multi-targets and multi-pathways, provides theoretical support and scientific basis for traditional Chinese medicine matching further study and clinical application.
陈雪晴1 刘雁锥2 冯静3 罗苑苑4 李姗5. 基于网络药理学探究益气化痰方治疗新型冠状病毒肺炎的分子机制[J]. 中国医药导报, 2021, 18(24): 26-31.
CHEN Xueqing1 LIU Yanzhui2 FENG Jing3 LUO Yuanyuan4 LI Shan5. Investigation of the molecular mechanism of Yiqi Huatan Prescription in the treatment of coronavirus disease 2019 based on network pharmacology. 中国医药导报, 2021, 18(24): 26-31.
京公网安备 11010502046598号